Los Altos Hills, CA, United States of America

Ann Hsu

This inventor holds 27 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Impax Laboratories, Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Hsu. Retrieved from https://idiyas.com/inventor/ann-hsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 1)

% Patents Active = 92.6

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.6

ph-index = 12

Forward Citations = 472(Granted Patents)

Location History:

Los Altos Hills, CA (US) (2006 - 2018)
Hayward, CA (US) (2018 - 2024)

Company Filing History:

27 out of 29

Impax Laboratories, Inc.

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Muco-Adhesive

Controlled Release

Levodopa

Esters of Levodopa

Pharmaceutical Dosage Forms

Immediate Release

Carbidopa

Combination Dosage Forms

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691074 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2026-07-28),

2. 12491164 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-12-09),

3. 12403099 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-09-02),

4. 12303605 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-05-20),

5. 12274793 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-04-14),

6. 12178919 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2024-12-31),

7. 12178918 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2024-12-31),

8. 12128141 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2024-10-29),

9. 12064521 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2024-08-20),

10. 11666538 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2023-06-06),

11. 11622941 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2023-04-11),

12. 11357733 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2022-06-14),

13. 10987313 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2021-04-27),

14. 10973769 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2021-04-13),

15. 10688058 - Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof (2020-06-23),

Hello! I have gathered information about inventor Ann Hsu and her remarkable contributions to the world of technology. Let's delve into her inspiring journey as a trailblazing inventor.

Title: The Pioneering Spirit of Ann Hsu: A Trailblazer in Technological Innovation

Introduction: Ann Hsu, residing in Los Altos Hills, CA (US), is a visionary inventor whose relentless pursuit of innovation has truly set her apart in the ever-evolving tech landscape.

Latest Patents: Ann Hsu's latest patents showcase her expertise in the field, particularly her invention of muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa. This groundbreaking oral solid formulation includes a controlled release component coated with a muco-adhesive polymer, along with an immediate release component comprising carbidopa and levodopa.

Career Highlights: Ann Hsu's impressive portfolio boasts a total of 18 patents, solidifying her as a pioneering force in technological advancements. Her work at Impax Laboratories, Inc. has been instrumental in shaping the future of pharmaceutical innovations and controlled release formulations.

Collaborations: Throughout her career, Ann Hsu has collaborated with esteemed colleagues such as Jim H Kou and Laman L Alani, further enriching her innovative endeavors and fostering a culture of teamwork in the pursuit of technological excellence.

Conclusion: Ann Hsu's passion for creating cutting-edge technologies and her unwavering dedication to innovation have cemented her legacy as a trailblazer in the world of technology. Her contributions continue to inspire and drive forward progress in the realm of inventing and patenting.

I hope this article provides valuable insight into Ann Hsu's remarkable journey as an inventor. If you have any more specific requests or need further information, feel free to ask!

Profile summary based on public USPTO records.